bioRxiv · 10.1101/2021.06.10.447396
Scalable and Automated CRISPR-Based Strain Engineering Using Droplet Microfluidics
Abstract
We present a droplet-based microfluidic system that enables CRISPR-based gene editing and high-throughput screening on chip. The microfluidic device contains a 10 x 10 element array, each element containing sets of electrodes for two electric field actuated operations-electrowetting for merging droplets to mix reagents and electroporation for transformation. It can perform up to 100 genetic modifications in parallel, providing a scalable platform for generating the large number of engineered strains required for combinatorial optimization of genetic pathways and predictable bioengineering. We demonstrate the systems capabilities through CRISPR-based engineering of two test cases-1) disruption of the function of enzyme galactokinase (galK) in E. coli and 2) targeted engineering of glutamine synthetase gene (glnA) and blue-pigment synthetase (bpsA) enzyme to improve indigoidine production in E. coli.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Iwai, K., Wehrs, M., Garber, M., Sustarich, J., Washburn, L., Costello, Z., Kim, P. W., Ando, D., Gaillard, W. R., Hillson, N. J., Adams, P. D., Mukhopadhyay, A., Martin, H. G., Singh, A. K.. 2021-06-10. Scalable and Automated CRISPR-Based Strain Engineering Using Droplet Microfluidics. https://doi.org/10.1101/2021.06.10.447396
Cite the original work for its findings. Save a collection to share your selection of sources.